define dose limiting toxicity - EAS

約有 499,000 個結果

  1. Redefining Dose-Limiting Toxicity – Hematology

    https://www.hematologyandoncology.net/.../february-2015/redefining-dose-limiting-toxicity

    網頁SPV Dose-limiting toxicities (DLTs) traditionally are defined by the occurrence of severe toxicities during the first cycle of systemic cancer therapy. Such toxicities are assessed according to the National Cancer Institute’s Common Terminology Criteria for Adverse …

  2. Dose Limiting Toxicity (DLT) and Common Toxicity …

    https://onbiostatistics.blogspot.com/2015/01/dose-limitin…

    網頁2015年1月19日 · In a paper by Paoletti et al “Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT …

    • 預估閱讀時間: 7 分鐘

    • Defining dose-limiting toxicity for phase 1 trials of molecularly …

      https://pubmed.ncbi.nlm.nih.gov/24928189

      網頁Introduction: It is increasingly clear that definitions of dose-limiting toxicity (DLT) established for phase 1 trials of cytotoxic agents are not suitable for molecularly targeted …

      • 作者: Xavier Paoletti, Christophe Le Tourneau, Jaap Verweij, Lillian L. Siu, Lesley Seymour, Sophie Postel...
      • Publish Year: 2014

    • DOSE LIMITING TOXICITIES (DLT) Example : Escalation …

      https://case.edu/.../files/2018-06/Dose-Limiting-Toxicity.pdf · PDF 檔案

      網頁A dose limiting toxicity (DLT) is defined as any of the following [Agent X]-related adverse event (AE) that occurs during the DLT period, graded according to the NCI Common …

      • 檔案大小: 36KB
      • 頁面計數: 3

    • Dose-Limiting Toxicity | SpringerLink

      https://link.springer.com/referenceworkentry/10.1007/978-3-642-16483-5_1714

      網頁2017年3月10日 · Dose-Limiting Toxicity Dose-Limiting Toxicity Reference work entry First Online: 01 January 2017 135 Accesses Definition DLT; a specified quantity of a …

    • 其他人也問了以下問題
      Are dose-limiting toxicity definitions suitable for Molecularly targeted agents?
      Introduction: It is increasingly clear that definitions of dose-limiting toxicity (DLT) established for phase 1 trials of cytotoxic agents are not suitable for molecularly targeted agents because of specific toxicity profiles.

      Defining dose-limiting toxicity for phase 1 trials of molecularly

      pubmed.ncbi.nlm.nih.gov/24928189/
      搜尋: Are dose-limiting toxicity definitions suitable for Molecularly targeted agents?
      What is dose-limiting toxicity (DLT)?
      The definition of Dose-limiting Toxicity (DLT) is determined by the individual protocol, not the CTC or CTCAE. Although it would be convenient to assume that all Grade 3 adverse events based on CTC or CTCAE represent dose limiting toxicities, this may not be appropriate.

      Dose Limiting Toxicity (DLT) and Common Toxicity Criteria (CTC) / Co…

      onbiostatistics.blogspot.com/2015/01/dose-limiting-toxici…
      搜尋: What is dose-limiting toxicity (DLT)?
      What constitutes a dose-limiting toxicity in Phase I cancer clinical trials?
      Introduction: There is no consensus about what constitutes a dose-limiting toxicity (DLT) in phase I cancer clinical trials. We aimed to evaluate how DLTs are defined in phase I trials of molecularly targeted agents (MTA). Methods: We retrieved all phase I trials testing monotherapy with an MTA published in English after January 1 st, 2000.

      Abstract 1690: Definition of dose-limiting toxicity in phase I cancer

      aacrjournals.org/cancerres/article/71/8_Supplement/1690…
      搜尋: What constitutes a dose-limiting toxicity in Phase I cancer clinical trials?
      What are SPV dose-limiting toxicities?
      SPV Dose-limiting toxicities (DLTs) traditionally are defined by the occurrence of severe toxicities during the first cycle of systemic cancer therapy. Such toxicities are assessed according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE) classification,...

      Redefining Dose-Limiting Toxicity – Hematology & Oncology

      www.hematologyandoncology.net/archives/february-2015…
      搜尋: What are SPV dose-limiting toxicities?
      意見反應

    • Dose-limiting toxicity and maximum tolerated dose: still fit for …

      https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(15)00248-X/fulltext

      網頁2015年10月1日 · Dose-limiting toxicities are defined as those that are related to investigational medicinal products and deemed to be unacceptable, leading to restriction …

    • Definition of dose-limiting toxicity in phase I cancer clinical trials …

      https://www.esmo.org/content/download/10246/203032/file/ESMO-TAT-2011-Definition-of...

      網頁Definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents

    • Abstract 1690: Definition of dose-limiting toxicity in phase I cancer …

      https://aacrjournals.org/.../575394/Abstract-1690-Definition-of-dose-limiting-toxicity

      網頁2011年4月15日 · Abstract. Introduction: There is no consensus about what constitutes a dose-limiting toxicity (DLT) in phase I cancer clinical trials. We aimed to evaluate how …

    • On Biostatistics and Clinical Trials: Maximum Tolerable …

      https://onbiostatistics.blogspot.com/2021/07/maximum-tolerable-dose-mtd-and-dose.html

      網頁2021年7月25日 · Dose- limiting toxicity-DLT is defined as any drug-related grade 3 non-hematologic toxicity or grade 4 hematologic toxicity lasting >28 days after the last day …

    • definition of dose-limiting toxicity. | Download Table - ResearchGate

      https://www.researchgate.net/figure/definition-of-dose-limiting-toxicity_tbl1_325657250

      網頁Toxicity will be graded according to CTCAE v4.03 and dose-limiting toxicities are defined in Table 1. Late toxicity after three months from completion of treatment will be graded …



    Results by Google, Bing, Duck, Youtube, HotaVN